Sierra Oncology, Inc. (SRRA) Financials

NASDAQ Currency in USD Disclaimer

$0.00

north_east NA Past Year
Day's range
$0
Day's range
$0
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100MEarning20152015201620162017201720182018201920192020202020212021-26965.5%-26965.5%-26966%-26966%-26966.5%-26966.5%-26967%-26967%-26967.5%-26967.5%-26968%-26968%-26968.5%-26968.5%Profit Margin
Profit Margin
Revenue
Earnings

SRRA Income statement / Annual

Last year (2021), Sierra Oncology, Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2021, Sierra Oncology, Inc.'s net income was -$94.66 M. See Sierra Oncology, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $0.00 $300,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $300,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 1 0 0 0 0 0 0 0
Research and Development Expenses $67.15 M $45.12 M $53.25 M $41.08 M $30.16 M $33.90 M $26.36 M $19.08 M $2.84 M
General & Administrative Expenses $27.44 M $20.12 M $13.74 M $14.34 M $12.46 M $14.18 M $9.47 M $3.50 M $1.16 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $27.44 M $20.12 M $13.74 M $14.34 M $12.46 M $14.18 M $9.47 M $3.50 M $1.16 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $94.59 M $65.24 M $66.99 M $55.42 M $42.62 M $48.08 M $35.83 M $22.58 M $4.01 M
Cost And Expenses $94.59 M $65.24 M $66.99 M $55.42 M $42.62 M $48.08 M $35.83 M $22.58 M $4.01 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.72 M
Depreciation & Amortization $305,000.00 $238,000.00 $83,000.00 $111,000.00 $258,000.00 $197,000.00 $111,000.00 $12,000.00 $1,000.00
EBITDA -$94.36 M -$80.52 M -$88.35 M -$53.53 M -$41.60 M -$47.53 M -$53.09 M -$23.86 M -$4.11 M
EBITDA Ratio 0 -268.41 0 0 0 0 0 0 0
Operating Income Ratio 0 -216.47 0 0 0 0 0 0 0
Total Other Income/Expenses Net $0.00 -$15.82 M -$21.44 M $1.78 M $760,000.00 $351,000.00 -$17.38 M -$1.29 M -$2.83 M
Income Before Tax -$94.66 M -$80.76 M -$88.44 M -$53.64 M -$41.86 M -$47.72 M -$53.21 M -$23.87 M -$6.83 M
Income Before Tax Ratio 0 -269.2 0 0 0 0 0 0 0
Income Tax Expense -$3,000.00 $142,000.00 -$160,000.00 -$302,000.00 $156,000.00 $143,000.00 $55,000.00 $2,000.00 -$108,000.00
Net Income -$94.66 M -$80.90 M -$88.28 M -$53.34 M -$42.02 M -$47.87 M -$53.26 M -$23.87 M -$6.83 M
Net Income Ratio 0 -269.67 0 0 0 0 0 0 0
EPS -7.14 -7.7 -30.3 -30.16 -33.68 -63.32 -147.95 -56.76 -13.19
EPS Diluted -7.14 -7.7 -30.3 -30.16 -33.68 -63.32 -147.95 -56.76 -13.19
Weighted Average Shares Out $13.25 M $10.51 M $2.91 M $1.77 M $1.25 M $756,006.00 $359,987.00 $420,572.00 $518,099.00
Weighted Average Shares Out Diluted $13.25 M $10.51 M $2.91 M $1.77 M $1.25 M $756,006.00 $359,987.00 $420,572.00 $518,099.00
Link